Quarterly report · Q3

Period2023-01-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Operating income−¥108m2023-01-01 → 2023-09-30Cons.Operating income
Operating income¥501m2022-01-01 → 2022-09-30Cons.Operating income
Ordinary income−¥36m2023-01-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥904m2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥676m2022-01-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥37m2023-01-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥673m2022-01-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥118m2023-01-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥723m2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥467m2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥118m2023-01-01 → 2023-09-30Cons.Profit loss
Net income¥467m2022-01-01 → 2022-09-30Cons.Profit loss
Total assets¥7.0bnat 2023-09-30Cons.Assets
Total assets¥6.3bnat 2022-12-31Cons.Assets
Total assets¥5.8bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥733mat 2023-09-30Cons.Liabilities
Total liabilities¥761mat 2022-12-31Cons.Liabilities
Net assets / equity¥6.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥5.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥5.2bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥4.0bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥3.7bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥3.9bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.7bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow−¥405m2023-01-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.5bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥953m2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥269m2023-01-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥48m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥57m2022-01-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥812m2023-01-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥30m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥11m2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-5.452023-01-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-6.622023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.52022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.282022-01-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.112022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥34.472022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥22.272022-01-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio89.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio87.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.5%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 451
ItemContextValueUnit
Net cash provided by used in financing activitiesPrior1YTDDuration-11114000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration812449000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration116195000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration98030000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration1115193000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration236601000JPY
Cash and cash equivalentsPrior2YearInstant2240661000JPY
Cash and cash equivalentsPrior1YearInstant3679304000JPY
Cash and cash equivalentsPrior1QuarterInstant3355854000JPY
Cash and cash equivalentsCurrentQuarterInstant3915905000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)東海財務局長
Filing date cover pageFilingDateInstant2023-11-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第16期第3四半期(自 2023年7月1日 至 2023年9月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)ラクオリア創薬株式会社
Company name in english cover pageFilingDateInstantRaQualia Pharma Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役  武内 博文
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)愛知県名古屋市中村区名駅南一丁目21番19号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)052-446-6100(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)財務経理部長 杉山 英史
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)愛知県名古屋市中村区名駅南一丁目21番19号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)052-446-6100(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)財務経理部長 杉山 英史
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE25269
Fund codeFilingDateInstant-
Security codeFilingDateInstant45790
Filer name in japaneseFilingDateInstant
Original text (Japanese)ラクオリア創薬株式会社
Filer name in englishFilingDateInstantRaQualia Pharma Inc.
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-
Current fiscal year start dateFilingDateInstant2023-01-01
Current period end dateFilingDateInstant2023-09-30
Type of current periodFilingDateInstantQ3
Current fiscal year end dateFilingDateInstant2023-12-31
Previous fiscal year start dateFilingDateInstant2022-01-01
Comparative period end dateFilingDateInstant2022-09-30
Previous fiscal year end dateFilingDateInstant2022-12-31
Next fiscal year start dateFilingDateInstant-
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant-
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant-
Report amendment flagFilingDateInstantfalse

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass